tiprankstipranks
Advertisement
Advertisement

Intellia Therapeutics 16.7M share Secondary priced at $10.75

The deal size was increased to $180M in common stock from $150M in common stock. Jefferies, Goldman Sachs and Citi acted as joint book running managers for the offering.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1